Chronic sub-anesthetic ketamine induces permanent hypolocomotion and impairment of hippocampus in adolescent cynomolgus monkeys

Neurosci Lett. 2020 Jan 19:717:134702. doi: 10.1016/j.neulet.2019.134702. Epub 2019 Dec 19.

Abstract

Ketamine has gained increasing popularity in adolescent drug abusers worldwide. However, relatively little is known about the long-term effects of recreational ketamine on adolescent hippocampus. The present study investigates the effects of different periods (1, 3 and 6 months) of recreational ketamine administration on locomotor activity and neuron damage in the hippocampus of adolescent cynomolgus monkeys. 32 4-year-old male cynomolgus monkeys were divided into control, 1-month, 3-month and 6-month groups. All animals in ketamine groups received daily intravenous injection with 1 mg/kg ketamine in saline for respective 1, 3 or 6 months while control group received normal saline. Automatic behaviors were recorded for 10 min before and after ketamine and saline administration. Meanwhile, the markers of apoptosis in the hippocampus were assessed using terminal deoxynucleotidyl transferase-mediated biotinylated dUTP nick end labeling (TUNEL), electron microscopy and western blotting. Results showed that ketamine significantly decreased locomotor activity, increased apoptotic neurons and pro-apoptotic proteins, cleaved Caspase-3 and Bax, while decreased the anti-apoptotic protein Bcl-2 in the hippocampus after 6-month ketamine administration. Our study suggested that chronically recreational ketamine might induce hypolocomotion and neurotoxic effect via apoptotic pathway in adolescent hippocampus of monkeys.

Keywords: Abuse; Apoptosis; Cynomolgus monkeys; Hippocampus; Hypolocomotion; Ketamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Behavior, Animal / drug effects
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Ketamine / pharmacology*
  • Macaca fascicularis
  • Male
  • Neurons / drug effects*
  • Neurons / metabolism
  • Temporal Lobe / metabolism
  • bcl-2-Associated X Protein / drug effects
  • bcl-2-Associated X Protein / metabolism

Substances

  • Anesthetics
  • bcl-2-Associated X Protein
  • Ketamine